LONDON, Nov 17 (Reuters) - Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make to fight future pandemics, under new rules being drawn up by the World Health Organization and reviewed by Reuters.
During the pandemic, many deals that governments made with pharmaceutical companies have been kept confidential, giving them little scope to hold drugmakers accountable.
A spokesperson for the WHO said it was member states that were driving the current process towards a new agreement.
"The process is open, transparent, and with the input from other stakeholders, including any interested stakeholders and public, able to submit comments at public consultations."
The draft will be presented to them in full in a meeting on Friday, after being circulated earlier in the week.